Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses

Document Type

Article

Publication Date

1-1-2019

Abstract

Dengue virus (DENV) and Japanese encephalitis virus (JEV) are important arthropod-borne viruses from the Flaviviridae family. DENV is a global public health problem with significant social and economic impacts, especially in tropical and subtropical areas. JEV is a neurotropic arbovirus endemic to east and southeast Asia. There are no U.S. FDA-approved antiviral drugs available to treat or to prevent DENV and JEV infections, leaving nearly one-third of the world’s population at risk for infection. Therefore, it is crucial to discover potent antiviral agents against these viruses. Nucleoside analogs, as a class, are widely used for the treatment of viral infections. In this study, we discovered nucleoside analogs that possess potent and selective anti-JEV and anti-DENV activities across all serotypes in cell-based assay systems. Both viruses were susceptible to sugar-substituted 2=-C-methyl analogs with either cytosine or 7-deaza-7-fluoro-adenine nucleobases. Mouse studies confirmed the anti-DENV activity of these nucleoside analogs. Molecular models were assembled for DENV serotype 2 (DENV-2) and JEV RNA-dependent RNA polymerase replication complexes bound to nucleotide inhibitors. These models show similarities between JEV and DENV-2, which recognize the same nucleotide inhibitors. Collectively, our findings provide promising compounds and a structural rationale for the development of direct-acting antiviral agents with dual activity against JEV and DENV infections.

Keywords

Antiviral agents, Dengue virus, Japanese encephalitis virus, Nucleoside analogs

Divisions

tidrec

Funders

NIH (grant R21-AI-129607),Emory University Center for AIDS Research (NIH grant 2P30-AI-050409 to R.F.S.),Ministry of Higher Education, Malaysia (high-impact research grant E000087-20001 and long-range scheme grant LR001/2011F),National Institute of Science and Technology in Dengue and Host-Microorganism Interaction, a program funded by the Brazilian National Science Council (Brazil),Minas Gerais Foundation for Science (Brazil),Comissao de Apoio a Pessoal de Ensino Superior (Brazil)

Publication Title

Antimicrobial Agents and Chemotherapy

Volume

63

Issue

7

Publisher

American Society for Microbiology

This document is currently not available here.

Share

COinS